Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Learn which commodities offer high returns to enhance your investment portfolio. Make informed decisions to grow your wealth.
26,939 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
The National Association of Realtors reports a small February uptick in nar: pending home sales, but the index remain...
Memory chips power AI and data centers, but prices swing with cycles. This guide weighs whether micron stock bubble r...
Andreessen Horowitz's crypto unit closes its fifth fund at $2.2 billion, signaling a patient, long-horizon bet on cry...
Institutional appetite for bitcoin ETFs intensified, with roughly $1.15 billion flowing in over the latest week and a...
A growing number of retirees are reconsidering traditional withdrawal rules, choosing to front-load discretionary spe...
Regulators and lenders are accelerating a shift toward scale in mortgage services. The change threatens many smaller ...
NAR's REACH accelerator unveils six residential tech startups for 2026, signaling ongoing commitment to modernizing h...
U.S. health insurers rise as analysts forecast margin recovery and cost discipline. Humana jumps, UnitedHealth climbs...
May data from the NAHB Eye on Housing show input costs for residential construction accelerated, led by energy prices...
A high-profile insider sale sparked questions about Bandwidth and its stock. This in-depth guide explains what bandwi...
When you see alamos gold stock plummeting, it’s often more than a minor price swing. This article breaks down the mai...